Intraocular injection of tamoxifen-loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis (Q42166603)

17 October 2017

Intraocular injection of tamoxifen-loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis (English)

1 reference

17 October 2017

0 references

1 reference

Karine Andrieux

2

0 references

Patrick Couvreur

series ordinal

8

object named as

Patrick Couvreur

1 reference

17 October 2017

6

Marie-Christine Naud

1 reference

17 October 2017

1

Yvonne de Kozak

1 reference

17 October 2017

3

Henri Villarroya

1 reference

17 October 2017

Christophe Klein

4

1 reference

17 October 2017

Brigitte Thillaye-Goldenberg

series ordinal

5

1 reference

17 October 2017

Elisabeth Garcia

series ordinal

7

1 reference

17 October 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

European Journal of Immunology

17 October 2017

1 reference

17 October 2017

34

1 reference

17 October 2017

3702-3712

1 reference

17 October 2017

12

1 reference

Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains

17 October 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

Oral feeding with ethinyl estradiol suppresses and treats experimental autoimmune encephalomyelitis in SJL mice and inhibits the recruitment of inflammatory cells into the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

The distribution of antigen in lymphoid tissues following its injection into the anterior chamber of the rat eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

APCs in the anterior uveal tract do not migrate to draining lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

Th1 and Th2 responses in pathogenesis and regulation of experimental autoimmune uveoretinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

7 January 2021

Effect of macrophage depletion by liposomes containing dichloromethylene-diphosphonate on endotoxin-induced uveitis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

7 January 2021

Marrow-derived activated macrophages are required during the effector phase of experimental autoimmune uveoretinitis in rats

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

7 January 2021

Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta-mediated breakdown.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

7 January 2021

Experimental autoimmune uveitis and its relationship to clinical ocular inflammatory disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

7 January 2021

Immune mechanisms of uveitis: insights into disease pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

7 January 2021

Cytokines in immunotherapy of experimental uveitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

7 January 2021

Inhibition of experimental autoimmune uveoretinitis by systemic and subconjunctival adenovirus-mediated transfer of the viral IL-10 gene

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

7 January 2021

Ocular transfer of retinal glial cells transduced ex vivo with adenovirus expressing viral IL-10 or CTLA4-Ig inhibits experimental autoimmune uveoretinitis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

7 January 2021

Tamoxifen: teaching an old drug new tricks?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

7 January 2021

Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

7 January 2021

The beneficial effects of treatment with tamoxifen and anti-oestradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulations

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

7 January 2021

Tamoxifen: new membrane-mediated mechanisms of action and therapeutic advances

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

7 January 2021

Risk of endometrial cancer after tamoxifen treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

7 January 2021

Tamoxifen retinopathy: does it really exist?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

7 January 2021

Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

7 January 2021

Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestrogen formulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

7 January 2021

Enhancement of collagen-induced arthritis in female mice by estrogen receptor blockage

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

7 January 2021

Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

7 January 2021

Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

7 January 2021

A gender gap in autoimmunity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

7 January 2021

Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hematopoietic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

7 January 2021

Anterior chamber associated immune deviation (ACAID): regulation, biological relevance, and implications for therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

7 January 2021

Presence of oestrogen receptor type beta in human retina

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

7 January 2021

Oestrogen receptors in macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

7 January 2021

Delayed onset and decreased severity of experimental autoimmune uveoretinitis in mice lacking nitric oxide synthase type 2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425022

7 January 2021

Identifiers

DOI

10.1002/EJI.200425022

1 reference

17 October 2017

1 reference